Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.
- DOI
- 10.1002/ueg2.12170
- Published
- 2021 Dec
- Container
- United European gastroenterology journal
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/ueg2.12170,
title = {Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.},
author = {Goessens L and Colombel JF and Outtier A and Ferrante M and Sabino J and Judge C and Saeidi R and Rabbitt L and Armuzzi A and Domenech E and Michalopoulos G and Cremer A and García-Alonso FJ and Molnar T and Karmiris K and Gecse K and Van Oostrom J and Löwenberg M and Farkas K and Atreya R and Ribaldone DG and Selinger C and Hoentjen F and Bihin B and Sebastian S and European COMBIO study group and Rahier JF},
year = {2021},
journal = {United European gastroenterology journal},
doi = {10.1002/ueg2.12170},
url = {https://doi.org/10.1002/ueg2.12170}
}RIS
TY - JOUR TI - Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study. AU - Goessens L AU - Colombel JF AU - Outtier A AU - Ferrante M AU - Sabino J AU - Judge C AU - Saeidi R AU - Rabbitt L AU - Armuzzi A AU - Domenech E AU - Michalopoulos G AU - Cremer A AU - García-Alonso FJ AU - Molnar T AU - Karmiris K AU - Gecse K AU - Van Oostrom J AU - Löwenberg M AU - Farkas K AU - Atreya R AU - Ribaldone DG AU - Selinger C AU - Hoentjen F AU - Bihin B AU - Sebastian S AU - European COMBIO study group AU - Rahier JF PY - 2021 JO - United European gastroenterology journal DO - 10.1002/ueg2.12170 UR - https://doi.org/10.1002/ueg2.12170 ER -
APA
L, G., JF, C., A, O., M, F., J, S., C, J., R, S., L, R., A, A., E, D., G, M., A, C., FJ, G., T, M., K, K., K, G., J, V. O., M, L., K, F., R, A., DG, R., C, S., F, H., B, B., S, S., group, E. C. S., & JF, R. (2021). Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.. United European gastroenterology journal. https://doi.org/10.1002/ueg2.12170
Source records
- pubmed · retrieved 2026-09-26T20:45:35.541Z
- europe-pmc · retrieved 2026-09-26T20:45:35.563Z